These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19793197)

  • 21. [Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma].
    Jiang MD
    Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):131-4, 189. PubMed ID: 7686810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association.
    Matthai SM; Ramakrishna B
    Indian J Med Res; 2015 Oct; 142(4):391-8. PubMed ID: 26609030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinoma.
    Yamamoto T; Uenishi T; Ogawa M; Ichikawa T; Hai S; Sakabe K; Tanaka S; Kato H; Mikami S; Ikebe T; Tanaka H; Ito S; Kaneda K; Hirohashi K; Kubo S
    Dig Surg; 2005; 22(5):364-70. PubMed ID: 16374007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI features of hepatocellular carcinoma expressing progenitor cell markers.
    Jeong HT; Kim MJ; Kim YE; Park YN; Choi GH; Choi JS
    Liver Int; 2012 Mar; 32(3):430-40. PubMed ID: 22097930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.
    Zhang F; Chen XP; Zhang W; Dong HH; Xiang S; Zhang WG; Zhang BX
    Histopathology; 2008 Jan; 52(2):224-32. PubMed ID: 18184271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma.
    Sansonno D; Cornacchiulo V; Racanelli V; Dammacco F
    Cancer; 1997 Jul; 80(1):22-33. PubMed ID: 9210705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of EpCAM increases in the hepatitis B related and the treatment-resistant hepatocellular carcinoma.
    Kimura O; Kondo Y; Kogure T; Kakazu E; Ninomiya M; Iwata T; Morosawa T; Shimosegawa T
    Biomed Res Int; 2014; 2014():172913. PubMed ID: 24696843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T; Budhu A; Forgues M; Wang XW
    Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture.
    Hoh A; Dewerth A; Vogt F; Wenz J; Baeuerle PA; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Liver Int; 2013 Jan; 33(1):127-36. PubMed ID: 23088518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma.
    Bae JS; Noh SJ; Jang KY; Park HS; Chung MJ; Park CK; Moon WS
    Int J Oncol; 2012 Dec; 41(6):2150-8. PubMed ID: 22993038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
    J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma.
    Lai JP; Conley A; Knudsen BS; Guindi M
    Histopathology; 2015 Oct; 67(4):442-50. PubMed ID: 25425262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area.
    Paterlini P; Driss F; Nalpas B; Pisi E; Franco D; Berthelot P; Bréchot C
    Hepatology; 1993 Jan; 17(1):20-9. PubMed ID: 8380790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice.
    Ogasawara S; Akiba J; Nakayama M; Nakashima O; Torimura T; Yano H
    J Gastroenterol Hepatol; 2015 Feb; 30(2):413-20. PubMed ID: 25087473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors.
    Bogaerts E; Heindryckx F; Devisscher L; Paridaens A; Vandewynckel YP; Van den Bussche A; Verhelst X; Libbrecht L; van Grunsven LA; Geerts A; Van Vlierberghe H
    PLoS One; 2015; 10(3):e0119555. PubMed ID: 25793288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma.
    Dai XM; Huang T; Yang SL; Zheng XM; Chen GG; Zhang T
    Dis Markers; 2017; 2017():8495326. PubMed ID: 28572700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.